240 related articles for article (PubMed ID: 16181415)
1. Immobilization stress causes increases in tetrahydrobiopterin, dopamine, and neuromelanin and oxidative damage in the nigrostriatal system.
Kim ST; Choi JH; Chang JW; Kim SW; Hwang O
J Neurochem; 2005 Oct; 95(1):89-98. PubMed ID: 16181415
[TBL] [Abstract][Full Text] [Related]
2. Loss of striatal dopaminergic fibers after intraventricular injection of tetrahydrobiopterin in rat brain.
Kim ST; Chang JW; Hong HN; Hwang O
Neurosci Lett; 2004 Apr; 359(1-2):69-72. PubMed ID: 15050714
[TBL] [Abstract][Full Text] [Related]
3. Long-term glial cell line-derived neurotrophic factor overexpression in the intact nigrostriatal system in rats leads to a decrease of dopamine and increase of tetrahydrobiopterin production.
Sajadi A; Bauer M; Thöny B; Aebischer P
J Neurochem; 2005 Jun; 93(6):1482-6. PubMed ID: 15935064
[TBL] [Abstract][Full Text] [Related]
4. Tetrahydrobiopterin is released from and causes preferential death of catecholaminergic cells by oxidative stress.
Choi HJ; Jang YJ; Kim HJ; Hwang O
Mol Pharmacol; 2000 Sep; 58(3):633-40. PubMed ID: 10953058
[TBL] [Abstract][Full Text] [Related]
5. Tetrahydrobiopterin causes mitochondrial dysfunction in dopaminergic cells: implications for Parkinson's disease.
Choi HJ; Lee SY; Cho Y; No H; Kim SW; Hwang O
Neurochem Int; 2006 Mar; 48(4):255-62. PubMed ID: 16343695
[TBL] [Abstract][Full Text] [Related]
6. L-deprenyl protects against rotenone-induced, oxidative stress-mediated dopaminergic neurodegeneration in rats.
Saravanan KS; Sindhu KM; Senthilkumar KS; Mohanakumar KP
Neurochem Int; 2006 Jul; 49(1):28-40. PubMed ID: 16490285
[TBL] [Abstract][Full Text] [Related]
7. Acute neurotoxic effects of the fungal metabolite ochratoxin-A.
Sava V; Reunova O; Velasquez A; Harbison R; Sánchez-Ramos J
Neurotoxicology; 2006 Jan; 27(1):82-92. PubMed ID: 16140385
[TBL] [Abstract][Full Text] [Related]
8. Matrix metalloproteinase-3 contributes to vulnerability of the nigral dopaminergic neurons.
Kim ST; Kim EM; Choi JH; Son HJ; Ji IJ; Joh TH; Chung SJ; Hwang O
Neurochem Int; 2010 Jan; 56(1):161-7. PubMed ID: 19815046
[TBL] [Abstract][Full Text] [Related]
9. Protective effect of bromocriptine against BH4-induced Cath.a cell death involving up-regulation of antioxidant enzymes.
Lim JH; Kim SS; Boo DH; No H; Kang BY; Kim EM; Hwang O; Choi HJ
Neurosci Lett; 2009 Feb; 451(3):185-9. PubMed ID: 19146917
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of vesicular monoamine transporter enhances vulnerability of dopaminergic cells: relevance to Parkinson's disease.
Choi HJ; Lee SY; Cho Y; Hwang O
Neurochem Int; 2005 Mar; 46(4):329-35. PubMed ID: 15707697
[TBL] [Abstract][Full Text] [Related]
11. Neuroprotective and neurorescue effect of black tea extract in 6-hydroxydopamine-lesioned rat model of Parkinson's disease.
Chaturvedi RK; Shukla S; Seth K; Chauhan S; Sinha C; Shukla Y; Agrawal AK
Neurobiol Dis; 2006 May; 22(2):421-34. PubMed ID: 16480889
[TBL] [Abstract][Full Text] [Related]
12. Estrogen modifies stress response of catecholamine biosynthetic enzyme genes and cardiovascular system in ovariectomized female rats.
Serova LI; Maharjan S; Sabban EL
Neuroscience; 2005; 132(2):249-59. PubMed ID: 15802180
[TBL] [Abstract][Full Text] [Related]
13. Particular vulnerability of rat mesencephalic dopaminergic neurons to tetrahydrobiopterin: Relevance to Parkinson's disease.
Lee SY; Moon Y; Hee Choi D; Jin Choi H; Hwang O
Neurobiol Dis; 2007 Jan; 25(1):112-20. PubMed ID: 17049260
[TBL] [Abstract][Full Text] [Related]
14. Neurodegenerative alterations in the nigrostriatal system of trkB hypomorphic mice.
Zaman V; Nelson ME; Gerhardt GA; Rohrer B
Exp Neurol; 2004 Dec; 190(2):337-46. PubMed ID: 15530873
[TBL] [Abstract][Full Text] [Related]
15. Increases in TH immunoreactivity, neuromelanin and degeneration in the substantia nigra of middle aged mice.
Kim ST; Choi JH; Kim D; Hwang O
Neurosci Lett; 2006 Apr; 396(3):263-8. PubMed ID: 16377085
[TBL] [Abstract][Full Text] [Related]
16. Role of cyclooxygenase-2 in tetrahydrobiopterin-induced dopamine oxidation.
Chae SW; Bang YJ; Kim KM; Lee KY; Kang BY; Kim EM; Inoue H; Hwang O; Choi HJ
Biochem Biophys Res Commun; 2007 Aug; 359(3):735-41. PubMed ID: 17560944
[TBL] [Abstract][Full Text] [Related]
17. Reduction of dopaminergic degeneration and oxidative stress by inhibition of angiotensin converting enzyme in a MPTP model of parkinsonism.
Muñoz A; Rey P; Guerra MJ; Mendez-Alvarez E; Soto-Otero R; Labandeira-Garcia JL
Neuropharmacology; 2006 Jul; 51(1):112-20. PubMed ID: 16678218
[TBL] [Abstract][Full Text] [Related]
18. Dopaminergic and serotoninergic deficiencies in young adult rats prenatally exposed to the bacterial lipopolysaccharide.
Wang S; Yan JY; Lo YK; Carvey PM; Ling Z
Brain Res; 2009 Apr; 1265():196-204. PubMed ID: 19236855
[TBL] [Abstract][Full Text] [Related]
19. Degeneration of the nigrostriatal pathway and induction of motor deficit by tetrahydrobiopterin: an in vivo model relevant to Parkinson's disease.
Kim SW; Jang YJ; Chang JW; Hwang O
Neurobiol Dis; 2003 Jul; 13(2):167-76. PubMed ID: 12828940
[TBL] [Abstract][Full Text] [Related]
20. Metabolism of tetrahydrobiopterin: its relevance in monoaminergic neurons and neurological disorders.
Ichinose H; Nomura T; Sumi-Ichinose C
Chem Rec; 2008; 8(6):378-85. PubMed ID: 19107867
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
